Executing an impactful urinary tract cancers strategy – when opportunity grabs you by the hand
In this blog post Aqsens Health’s CEO and Co-founder Timo Teimonen recounts Aqsens’ urinary tract cancer strategy journey and discusses the importance of international collaboration and multidisciplinary approaches in advancing cancer research.
Strengthening Aqsens Health’s board with diagnostics market expertise
We're pleased to welcome Paul Eros to our Board of Directors and announce Pekka Hänninen as our new Chairman. We're deeply grateful to Aaron Michelin for his contributions and look forward to continued collaboration.
What are Phages? – A look into their history and applications
Vilhelmiina Juusti Appointed as a COO of Aqsens Health Oy Ltd.
Aqsens Health Oy Ltd., a leading provider of biosensor based analysis, is pleased to announce the appointment of Vilhelmiina Juusti as its new Chief Operating Officer (COO).
Could biosensors enable better prediction for organ transplantation rejection – a research project with the Department of Medicine, Harvard Medical School Lung Transplantation team
Aqsens Health had a chance to interview Dr. Mohd Moin Khan and Dr. Mudassir Meraj Banday, research fellows at Harvard University, about their research, this collaboration, and how we could use biosensors in the future to help predict the likelihood of rejection in organ transplants. Below are their answers to our questions.
Daily Decisions, Lasting Effects: Impacting Your Cancer Risk – World Cancer Day 2024
Did you know that a third of the most prevalent cancers can be prevented through simple, healthy lifestyle choices? According to the World Health Organization (WHO), embracing specific changes in your daily routine and adopting evidence-based prevention strategies can help steer clear of approximately 30% to 50% of cancer-related deaths.
Kicking-off saliva based Parkinson’s disease detection study using E-TRF and biosensors – Interview with Professor Valtteri Kaasinen from University of Turku
Aqsens Health is excited to take part in a cross-disciplinary Parkinson’s disease study in collaboration with Professor Valtteri Kaasinen from The Department of Clinical Neurosciences at the University of Turku. The aim of the study is to improve Parkinson’s disease’s diagnostic accuracy with Aqsens’ E-TRF and biosensor technology and smell detection dogs. We had the pleasure to interview Professor Kaasinen about Parkinson’s disease (PD), its diagnostics, and how this study could help improve diagnostics in the future.